XBiotech Inc. Operating Income Loss

• XBiotech Inc. showed a decrease of -31.1% in Operating Income Loss from 2024 to 2025.
• This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), XBiotech Inc.'s Operating Income Loss has declined by 461.1%.
• Historical annual values: Fiscal year 2025: -$55.69 million | Fiscal year 2024: -$42.47 million | Fiscal year 2023: -$37.51 million | Fiscal year 2022: -$34.49 million | Fiscal year 2021: -$25.08 million | Fiscal year 2020: -$18.28 million | Fiscal year 2019: -$31.23 million | Fiscal year 2018: -$20.99 million | Fiscal year 2017: -$34.06 million | Fiscal year 2016: -$52.76 million | Fiscal year 2015: -$37.51 million | Fiscal year 2014: -$21.78 million | Fiscal year 2013: -$9.93 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026